Vinmec Research Institute Of Stem Cell And Gene Technology

This early-phase study tests the safety of a new treatment for liver cirrhosis. The therapy uses tiny particles (extracellular vesicles) from umbilical cord stem cells, given through a vein. Up to 12 adults with moderate-to-severe liver damage will receive increasing doses to see…

This early-stage trial tests a treatment called CD19 CAR T-cell therapy for people with severe lupus that hasn't improved with standard medicines. The therapy uses a patient's own immune cells, which are modified in a lab to better target and attack lupus-causing cells. The main …